This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Microcrystalline cellulose
- DrugBank Accession Number
- DB14158
- Background
A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations.
- Type
- Small Molecule
- Groups
- Approved, Experimental, Investigational
- Synonyms
- Cellulose
- Cellulose crystalline
- Cellulose powder
- Cellulose regenerated
- Cellulose, microcrystalline
- Cellulose, powder
- Cellulose, powdered
- Hydroxycellulose
- Powdered cellulose
- Pyrocellulose
- Rayon
- External IDs
- CP-305
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Symptomatic treatment of Vaginal burning sensation ••• ••• Symptomatic treatment of Vaginal itching ••• ••• - Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- No interactions found.
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Cellzyme Secret Therapy 3845 Microcrystalline cellulose (0.0015 g/100mL) + Allantoin (0.145 g/100mL) + Glycerin (5.2 g/100mL) Cream Topical PHARMACAL-INTERNATIONAL. CO., LTD 2017-08-16 Not applicable US 
Cellzyme Secret Therapy 3845 Microcrystalline cellulose (0.0015 g/100mL) + Allantoin (0.145 g/100mL) + Glycerin (5.2 g/100mL) Cream Topical PHARMACAL-INTERNATIONAL. CO., LTD 2017-08-16 Not applicable US MELART Microcrystalline cellulose (103.8 mg) + Meloxicam (15 mg) Tablet Oral NUTRI MACK S.A.S. 2022-09-24 Not applicable Colombia 
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- BX81F82EWG
- CAS number
- 9004-34-6
References
- General References
- Not Available
- External Links
- 2221
- Wikipedia
- Microcrystalline_cellulose
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample dataNot Available Completed Basic Science Biomechanics / Caffeine / Fatigue / Injury / Physical Activities 1 somestatus stop reason just information to hide Not Available Completed Treatment Hypertension / Type 2 Diabetes Mellitus 1 somestatus stop reason just information to hide Not Available Completed Treatment Obesity, Morbid 1 somestatus stop reason just information to hide Not Available Terminated Prevention Postpartum Depression 1 somestatus stop reason just information to hide Not Available Unknown Status Treatment Elbow Trauma Requiring Operative Management 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Tablet Oral 25.540 mg Cream Topical Tablet Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
- Not Available
- Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at June 29, 2018 15:08 / Updated at September 28, 2021 21:54